-
1
-
-
0016177627
-
A novel adenosine and Ara-A inhibitor, (R)-3(2-deoxy-β-D-erythopentofuranosyl)-3,6,7,8, tetra-hydro-imidazole (4-5d)(1-3)diazepin8-ol
-
Woo PWK, Dion HW, Lange SM,et al.A novel adenosine and Ara-A inhibitor, (R)-3(2-deoxy-β-D-erythopentofuranosyl)-3,6,7,8, tetra-hydro-imidazole (4-5d)(1-3)diazepin8-ol. J Heterocycl Chem. 1974; 11:641-643.
-
(1974)
J Heterocycl Chem.
, vol.11
, pp. 641-643
-
-
Woo, P.W.K.1
Dion, H.W.2
Lange, S.M.3
-
2
-
-
0022382997
-
Study on the inhibition of adenosine deaminase
-
Montgomery JH, Thomas HJ, Zell EL,et al.Study on the inhibition of adenosine deaminase. J Med Chem. 1985;28:1751-1753.
-
(1985)
J Med Chem.
, vol.28
, pp. 1751-1753
-
-
Montgomery, J.H.1
Thomas, H.J.2
Zell, E.L.3
-
3
-
-
0021958568
-
Spontaneous epimerization of S-deoxycoformycin and interaction of R-deoxycoformycin, S-deoxycoformycin, and 8-ketodeoxycoformycin with adenosine deaminase
-
Schramm VL, Baker DC Spontaneous epimerization of S-deoxycoformycin and interaction of R-deoxycoformycin, S-deoxycoformycin, and 8-ketodeoxycoformycin with adenosine deaminase. Biocbemistry. 1985;24:6641-6649.
-
(1985)
Biocbemistry
, vol.24
, pp. 6641-6649
-
-
Schramm, V.L.1
Baker, D.C.2
-
4
-
-
0025742995
-
Transport of 2'-deoxycoformycin in human leukemia and lymphoma cells
-
Willey JS, Smith CL, Jameson GP Transport of 2'-deoxycoformycin in human leukemia and lymphoma cells. Biochem Pharmacol. 1991;42:708-710.
-
(1991)
Biochem Pharmacol.
, vol.42
, pp. 708-710
-
-
Willey, J.S.1
Smith, C.L.2
Jameson, G.P.3
-
5
-
-
0027097544
-
Pentostatin: Future directions
-
Klohs WD, Kraker AJ Pentostatin: future directions. Pharm Rev. 1992;44:459-477.
-
(1992)
Pharm Rev
, vol.44
, pp. 459-477
-
-
Klohs, W.D.1
Kraker, A.J.2
-
6
-
-
0016774329
-
The effect of external deoxynucleosides on deoxyribonucleoside triphosphate concentration in human lymphocytes
-
Tattersal MHN, Ganeshaguru K., Hoffbrand AV The effect of external deoxynucleosides on deoxyribonucleoside triphosphate concentration in human lymphocytes. Biocbem PbarinacoL 1975;24:1495-1498.
-
(1975)
Biocbem PbarinacoL
, vol.24
, pp. 1495-1498
-
-
Tattersal, M.H.N.1
Ganeshaguru, K.2
Hoffbrand, A.V.3
-
7
-
-
0018103017
-
Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: A model for immunodeficiency disease
-
Ullman B., Gudas LJ, Cohen A.,et al.Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease. Cell. 1978; 14:365-375.
-
(1978)
Cell.
, vol.14
, pp. 365-375
-
-
Ullman, B.1
Gudas, L.J.2
Cohen, A.3
-
8
-
-
0024271195
-
Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo
-
Ho AD, Ganeshaguru K., Knauf WU,et al.Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo. Blood. 1988;72:1884-1890.
-
(1988)
Blood.
, vol.72
, pp. 1884-1890
-
-
Ho, A.D.1
Ganeshaguru, K.2
Knauf, W.U.3
-
9
-
-
0020369638
-
Role of DNA breaks and ADP-ribosyl transferase activity in eukaryotic differentiation demonstrated in human lymphocytes
-
Johnstone AP, Williams GT Role of DNA breaks and ADP-ribosyl transferase activity in eukaryotic differentiation demonstrated in human lymphocytes. Nature. 1982;300:368-370.
-
(1982)
Nature
, vol.300
, pp. 368-370
-
-
Johnstone, A.P.1
Williams, G.T.2
-
10
-
-
0021050706
-
Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism
-
Cohen A., Barankiewicz J., Lederman HM,et al.Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism. J Biol Cbem. 1983;258:12334-12340.
-
(1983)
J Biol Cbem
, vol.258
, pp. 12334-12340
-
-
Cohen, A.1
Barankiewicz, J.2
Lederman, H.M.3
-
11
-
-
0026783019
-
Induction of apoptosis in CD4+ prolymphocytic leukemia by deoxyadenosine and 2'-deoxycoformycin
-
Johnston JB, Lee K., Verburb L.,et al.Induction of apoptosis in CD4+ prolymphocytic leukemia by deoxyadenosine and 2'-deoxycoformycin. Leuk Res. 1992;16:781-788.
-
(1992)
Leuk Res
, vol.16
, pp. 781-788
-
-
Johnston, J.B.1
Lee, K.2
Verburb, L.3
-
12
-
-
0019521591
-
Clinical pharmacology of 2-deoxycoformycin
-
Major PP, Agarwal RP, Kufe DW Clinical pharmacology of 2-deoxycoformycin. Blood. 1981a;58:91-96.
-
(1981)
Blood.
, vol.58
, pp. 91-96
-
-
Major, P.P.1
Agarwal, R.P.2
Kufe, D.W.3
-
14
-
-
0019835982
-
Levels of 2-deoxycoformycin and deoxyadenosine in patients with acute lymphoblastic leukemia
-
Venner PM, Glazer RI, Blatt J.,et al.Levels of 2-deoxycoformycin and deoxyadenosine in patients with acute lymphoblastic leukemia. Cancer Res. 1981;41:4508-4511.
-
(1981)
Cancer Res.
, vol.41
, pp. 4508-4511
-
-
Venner, P.M.1
Glazer, R.I.2
Blatt, J.3
-
15
-
-
0027422366
-
Pentostatin: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in lymphoproliferative disorders
-
Brogden RN, Sorkin EM Pentostatin: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in lymphoproliferative disorders. Drugs. 1993;46:652- 677.
-
(1993)
Drugs.
, vol.46
, pp. 652-677
-
-
Brogden, R.N.1
Sorkin, E.M.2
-
17
-
-
0019127565
-
The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin
-
Smyth JF, Paine RM, Jackman AL,et al.The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin. Cancer Chemother Pharmacol. 1980;5:93-101.
-
(1980)
Cancer Chemother Pharmacol.
, vol.5
, pp. 93-101
-
-
Smyth, J.F.1
Paine, R.M.2
Jackman, A.L.3
-
18
-
-
0019512909
-
The biochemical and clinical consequences of pentostatin in refractory lymphoproliferative malignancy
-
Grever MR, Slaw Mfe, Jacob WF,et al.The biochemical and clinical consequences of pentostatin in refractory lymphoproliferative malignancy. Blood. 1981;57:406-417.
-
(1981)
Blood.
, vol.57
, pp. 406-417
-
-
Grever, M.R.1
Slaw, M.F.E.2
Jacob, W.F.3
-
19
-
-
0019467252
-
Phase 1 study of 2'-deoxycoformycin in acute lymphoblastic leukemias
-
3435-3346
-
Poplack DG, Sallen SE, Rever G.,et al.Phase 1 study of 2'-deoxycoformycin in acute lymphoblastic leukemias. Cancer Res. 1981;41:3435-3346.
-
(1981)
Cancer Res.
, vol.41
-
-
Poplack, D.G.1
Sallen, S.E.2
Rever, G.3
-
20
-
-
0019521591
-
Clinical pharmacology of deoxycoformycin
-
Major PP, Agarwal RP, Kufe DW Clinical pharmacology of deoxycoformycin. Blood. 1981;58:91-96.
-
(1981)
Blood.
, vol.58
, pp. 91-96
-
-
Major, P.P.1
Agarwal, R.P.2
Kufe, D.W.3
-
21
-
-
0026875687
-
Phase I study of YK-176 (2'-deoxycoformycin) in patients with adult T-cell leukemia-lymphoma. The DCF Study Group
-
Tobinai K., Shimoyama M., Inoue S.,et al.Phase I study of YK-176 (2'-deoxycoformycin) in patients with adult T-cell leukemia-lymphoma. The DCF Study Group. Jpn J Clin Oncol. 1992;22:164-171.
-
(1992)
Jpn J Clin Oncol.
, vol.22
, pp. 164-171
-
-
Tobinai, K.1
Shimoyama, M.2
Inoue, S.3
-
22
-
-
0022272745
-
Deoxycoformycin in the treatment of leukemias and lymphomas
-
Smyth JF, Prentice HG, Proctor S.,et al.Deoxycoformycin in the treatment of leukemias and lymphomas. Ann N YAcad Sci. 1985;451:123-128.
-
(1985)
Ann N YAcad Sci.
, vol.451
, pp. 123-128
-
-
Smyth, J.F.1
Prentice, H.G.2
Proctor, S.3
-
23
-
-
0021933387
-
Low dose deoxycoformycin in lymphoid malignancy
-
Grever MR, Leiby JM, Kraut EH,et al.Low dose deoxycoformycin in lymphoid malignancy. J Clin Oncol. 1985;3:1196-1201.
-
(1985)
J Clin Oncol.
, vol.3
, pp. 1196-1201
-
-
Grever, M.R.1
Leiby, J.M.2
Kraut, E.H.3
-
24
-
-
0024551346
-
Pentostatin in chronic lymphocytic leukemia: A phase 2 trial of the Cancer and Leukemia Group B
-
Dillman RO, Mick R., McIntyre OR Pentostatin in chronic lymphocytic leukemia: a phase 2 trial of the Cancer and Leukemia Group B. J Clin Oncol. 1989; 7:433- 438.
-
(1989)
J Clin Oncol.
, vol.7
-
-
Dillman, R.O.1
Mick, R.2
McIntyre, O.R.3
-
25
-
-
0025045158
-
Pentostatin in refractory chronic lymphocytic leukemia: A phase 2 trial by the European Organization for Research and Treatment of Cancer
-
Ho AD, Thaler J., Stryckmans P.,et al.Pentostatin in refractory chronic lymphocytic leukemia: a phase 2 trial by the European Organization for Research and Treatment of Cancer. J Natl Cancer Inst. 1990;82: 1416-1420.
-
(1990)
J Natl Cancer Inst.
, vol.82
, pp. 1416-1420
-
-
Ho, A.D.1
Thaler, J.2
Stryckmans, P.3
-
26
-
-
0025283382
-
Deoxycoformycin in the treatment of mature B-cell malignancies
-
Deardon C., Catovsky D. Deoxycoformycin in the treatment of mature B-cell malignancies. Br J Cancer. 1990;62:4-5.
-
(1990)
Br J Cancer.
, vol.62
, pp. 4-5
-
-
Deardon, C.1
Catovsky, D.2
-
27
-
-
0026573542
-
Treatment of hairy cell leukemia
-
Saven A., Piro LD Treatment of hairy cell leukemia. Blood. 1992;79(5):1111-1120.
-
(1992)
Blood.
, vol.79
, Issue.5
, pp. 1111-1120
-
-
Saven, A.1
Piro, L.D.2
-
28
-
-
0023571468
-
Treatment of hairy cell leukemia. The Ohio State experience with deoxycoformycin
-
Bouroncle BA, Grever MR, Kraught EH Treatment of hairy cell leukemia. The Ohio State experience with deoxycoformycin. Leukemia. 1987;4:350-354.
-
(1987)
Leukemia
, vol.4
, pp. 350-354
-
-
Bouroncle, B.A.1
Grever, M.R.2
Kraught, E.H.3
-
29
-
-
0024317929
-
Response to pentostatin in hairy cell leukemia refractory to interferon-alpha
-
Ho AD, Thaiser J., Mandelli F.,et al.Response to pentostatin in hairy cell leukemia refractory to interferon-alpha. J Clin Oncol. 1989;7:1533-1538.
-
(1989)
J Clin Oncol.
, vol.7
, pp. 1533-1538
-
-
Ho, A.D.1
Thaiser, J.2
Mandelli, F.3
-
30
-
-
0024590995
-
Pentostatin in the treatment of advanced hairy cell leukemia
-
Kraut EH, Bouroncle BA, Grever MR,et al.Pentostatin in the treatment of advanced hairy cell leukemia. J Clin Oncol. 1989;7:168-172.
-
(1989)
J Clin Oncol.
, vol.7
, pp. 168-172
-
-
Kraut, E.H.1
Bouroncle, B.A.2
Grever, M.R.3
-
31
-
-
0023680603
-
Efficacy of 2'-deoxycoformycin in hairy cell leukemia: A study of the National Cancer Institute Canada Clinical Working Trials Group
-
Johnston JB, Eisenhauer E., Corbett WEN,et al.Efficacy of 2'-deoxycoformycin in hairy cell leukemia: a study of the National Cancer Institute Canada Clinical Working Trials Group. J Natl Cancer Inst. 1988;80:765-766.
-
(1988)
J Natl Cancer Inst.
, vol.80
, pp. 765-766
-
-
Johnston, J.B.1
Eisenhauer, E.2
Corbett, W.E.N.3
-
32
-
-
0023111435
-
Remissions in hairy cell leukemia with pentostatin (2'-deoxycoformycin)
-
Spiers ASD, Moore D., Cassileth PA,et al.Remissions in hairy cell leukemia with pentostatin (2'-deoxycoformycin). N Engl J Med. 1987;316:825-831.
-
(1987)
N Engl J Med.
, vol.316
, pp. 825-831
-
-
Spiers, A.S.D.1
Moore, D.2
Cassileth, P.A.3
-
33
-
-
0025169752
-
Durable complete remissions after 2'-deoxycoformycin treatment in patients with hairy cell leukemia resistant to interferon alpha
-
Blick M., Lepe-Zuniga JL, Doig R.,et al.Durable complete remissions after 2'-deoxycoformycin treatment in patients with hairy cell leukemia resistant to interferon alpha. Am J Hematol. 1990;33:205-209.
-
(1990)
Am J Hematol
, vol.33
, pp. 205-209
-
-
Blick, M.1
Lepe-Zuniga, J.L.2
Doig, R.3
-
34
-
-
0025980309
-
Pentostatin induces durable remissions in hairy cell leukemia
-
Cassileth PA, Cheuvant B., Spiers ASD,et al.Pentostatin induces durable remissions in hairy cell leukemia. J Clin Oncol. 1991;9:243-246.
-
(1991)
J Clin Oncol.
, vol.9
, pp. 243-246
-
-
Cassileth, P.A.1
Cheuvant, B.2
Spiers, A.S.D.3
-
35
-
-
0028929938
-
Randomized comparison of pentostatin vs interferon-a 2a in previously untreated patients with hairy cell leukemia
-
Grever M., Kopecky K., Foucar KM,et al.Randomized comparison of pentostatin vs interferon-a 2a in previously untreated patients with hairy cell leukemia. J Clin Oncol. 1995;13:974-982.
-
(1995)
J Clin Oncol.
, vol.13
, pp. 974-982
-
-
Grever, M.1
Kopecky, K.2
Foucar, K.M.3
-
36
-
-
0025236436
-
Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: Results of a phase II study
-
Martin A., Nerenstone S., Urba WJ,et al.Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study. J Clin Oncol. 1990;8:721-730.
-
(1990)
J Clin Oncol.
, vol.8
, pp. 721-730
-
-
Martin, A.1
Nerenstone, S.2
Urba, W.J.3
-
37
-
-
0026588745
-
Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukemia
-
Haberman TM, Anderson JW, Cassileth PA,et al.Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukemia. Br J Haematol. 1992;80:466- 471.
-
(1992)
Br J Haematol
, vol.80
-
-
Haberman, T.M.1
Anderson, J.W.2
Cassileth, P.A.3
-
38
-
-
0029869521
-
Pentostatin (2'-deoxycorformycin, dCf) in patients with low-grade (B-T-cell) and intermediate and high grade (T-cell) malignant lymphomas a phase II study of the EORTC Early Clinical Trials Group
-
Monfardini S., Sorio R., Cavalli F.,et al.Pentostatin (2'-deoxycorformycin, dCf) in patients with low-grade (B-T-cell) and intermediate and high grade (T-cell) malignant lymphomas a phase II study of the EORTC Early Clinical Trials Group. Oncology. 1996; 53:163-168.
-
(1996)
Oncology
, vol.53
, pp. 163-168
-
-
Monfardini, S.1
Sorio, R.2
Cavalli, F.3
-
39
-
-
0025308006
-
2'deoxycoformycin (pentostatin) for refractory non-Hodgkin's lymphoma: A CALGB phase II study
-
Duggan DA, Anderson JR, Dillman R.,et al.2'deoxycoformycin (pentostatin) for refractory non-Hodgkin's lymphoma: a CALGB phase II study. Med Pediatr Oncol. 1990;18:203-209.
-
(1990)
Med Pediatr Oncol.
, vol.18
, pp. 203-209
-
-
Duggan, D.A.1
Anderson, J.R.2
Dillman, R.3
-
40
-
-
0026087131
-
Phase II trial of pentostatin in refractory lymphomas and cutaneous T-cell disease
-
Cummings FJ, Kim K., Neiman RS,et al.Phase II trial of pentostatin in refractory lymphomas and cutaneous T-cell disease. J Clin Oncol. 1991;9:565-571.
-
(1991)
J Clin Oncol.
, vol.9
, pp. 565-571
-
-
Cummings, F.J.1
Kim, K.2
Neiman, R.S.3
-
41
-
-
0028151443
-
The role of pentostatin in the treatment of T-cell malignancies: Analysis of response rate in 145 patients according to disease subtype
-
Mercieca J., Matutes E., Deardon C., MacLennan, Catovsky D. The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype. J Clin Oncol. 1994; 12:2588-2593.
-
(1994)
J Clin Oncol.
, vol.12
, pp. 2588-2593
-
-
Mercieca, J.1
Matutes, E.2
Deardon, C.3
MacLennan Catovsky, D.4
-
42
-
-
0020670025
-
An investigation of 2'-deoxycoformycin in the treatment of cutaneous T-cell lymphoma
-
Grever MR, Bisaccia E., Scarborough DA,et al.An investigation of 2'-deoxycoformycin in the treatment of cutaneous T-cell lymphoma. Blood. 1983; 61:279-282.
-
(1983)
Blood.
, vol.61
, pp. 279-282
-
-
Grever, M.R.1
Bisaccia, E.2
Scarborough, D.A.3
-
44
-
-
0027076455
-
Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa 2a in advanced mycosis fungoides/Sezary syndrome
-
Foss FM, Ihde DC, Breneman DL,et al.Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa 2a in advanced mycosis fungoides/Sezary syndrome. J Clin Oncol. 1992;10: 1907-1913.
-
(1992)
J Clin Oncol.
, vol.10
, pp. 1907-1913
-
-
Foss, F.M.1
Ihde, D.C.2
Breneman, D.L.3
-
45
-
-
0025729043
-
Phase II study of 2'-deoxycoformycin in patients with renal cell carcinoma. A National Cancer Institute of Canada Clinical Trials Group study
-
Venner P., Eisenhauer EA, Wierzbicki R.,et al.Phase II study of 2'-deoxycoformycin in patients with renal cell carcinoma. A National Cancer Institute of Canada Clinical Trials Group study. Invest New Drugs. 1991;9:273-275.
-
(1991)
Invest New Drugs.
, vol.9
, pp. 273-275
-
-
Venner, P.1
Eisenhauer, E.A.2
Wierzbicki, R.3
-
46
-
-
0027096559
-
A phase II investigation of pentostatin in metastatic malignant melanoma
-
Grever MR, Brager P., Metz E. A phase II investigation of pentostatin in metastatic malignant melanoma. Invest New Drugs. 1992;10:345-346.
-
(1992)
Invest New Drugs.
, vol.10
, pp. 345-346
-
-
Grever, M.R.1
Brager, P.2
Metz, E.3
-
47
-
-
0025689969
-
Phase II investigation of pentostatin in multiple myeloma: A Southwest Oncology Group study
-
Grever MR, Crowley J., Salmon S.,et al.Phase II investigation of pentostatin in multiple myeloma: a Southwest Oncology Group study. J Natl Cancer Inst. 1990;22:1778-1779.
-
(1990)
J Natl Cancer Inst.
, vol.22
, pp. 1778-1779
-
-
Grever, M.R.1
Crowley, J.2
Salmon, S.3
-
48
-
-
0026454996
-
Lack of significant activity of 2'-deoxycoformycin alone or in combination with adenine arabinoside in relapsed childhood acute llymphoblastic leukemia: A randomized phase II trial from the Childrens Cancer Study Group
-
Miser JS, Roloff J., Blatt J.,et al.Lack of significant activity of 2'-deoxycoformycin alone or in combination with adenine arabinoside in relapsed childhood acute llymphoblastic leukemia: a randomized phase II trial from the Childrens Cancer Study Group. Am J Clin Oncol. 1992;15:490-493.
-
(1992)
Am J Clin Oncol.
, vol.15
, pp. 490-493
-
-
Miser, J.S.1
Roloff, J.2
Blatt, J.3
-
50
-
-
79957811427
-
-
Infectious and immunosuppressive complications of purine analogue therapy
-
Cheson BD. Infectious and immunosuppressive complications of purine analogue therapy.
-
-
-
Cheson, B.D.1
-
51
-
-
0022508693
-
Association of severe and fatal infections and treatment with pentostatin
-
O'Dwyer PJ, Spiers Asd, Maroni S.,et al.Association of severe and fatal infections and treatment with pentostatin. Cancer Treat Rep. 1986;70:117-120.
-
(1986)
Cancer Treat Rep.
, vol.70
, pp. 117-120
-
-
O'Dwyer, P.J.1
Spiers, A.S.D.2
Maroni, S.3
-
52
-
-
0023493235
-
The role of pentostatin (2'-deoxycoformycin) in the management of lymphoproliferative malignancies
-
Speirs ASD. The role of pentostatin (2'-deoxycoformycin) in the management of lymphoproliferative malignancies. Blood Rev. 1987;1:106-110.
-
(1987)
Blood Rev.
, vol.1
, pp. 106-110
-
-
Speirs, A.S.D.1
-
53
-
-
0017102172
-
Effects of adenosine analogs on rat cerebral cortical neurons
-
Phillis JW, Edstrom JP Effects of adenosine analogs on rat cerebral cortical neurons. Life Sci. 1976; 19: 1041-1054.
-
(1976)
Life Sci.
, vol.19
, pp. 1041-1054
-
-
Phillis, J.W.1
Edstrom, J.P.2
-
54
-
-
9544223741
-
Role of adenosine and adenine nucleotides in central nervous function
-
In: Baer HP, Drummond GI, eds., New York: Raven
-
Phillis JW, Kostopoulos JK, Edstrom JP,et al.Role of adenosine and adenine nucleotides in central nervous function. In: Baer HP, Drummond GI, eds. Physiological and regulatory functions of adenosine and adenine nucleotides. New York: Raven, 1979:343-359.
-
(1979)
Physiological and Regulatory Functions of Adenosine and Adenine Nucleotides
, pp. 343-359
-
-
Phillis, J.W.1
Kostopoulos, J.K.2
Edstrom, J.P.3
-
56
-
-
0019521591
-
Clinical pharmacology of deoxycoformycin
-
Major PP, Agarwal RP, Kufe DW Clinical pharmacology of deoxycoformycin. Blood. 1981;58:91-96.
-
(1981)
Blood.
, vol.58
, pp. 91-96
-
-
Major, P.P.1
Agarwal, R.P.2
Kufe, D.W.3
-
58
-
-
24044431915
-
A randomized comparison of deoxycoformycin (DCF) versus alpha-2a interferon (IFN) in previously untreated patients with hairy cell leukemia (HCL): An NCI sponsored intergroup study (SWOG, ECOG, CALGB, NCIC, CTG)
-
Grever M., Kopecky K., Head D.,et al.A randomized comparison of deoxycoformycin (DCF) versus alpha-2a interferon (IFN) in previously untreated patients with hairy cell leukemia (HCL): an NCI sponsored intergroup study (SWOG, ECOG, CALGB, NCIC, CTG). Proc Am Soc Clin Oncol. 1992;11:868.
-
(1992)
Proc Am Soc Clin Oncol.
, vol.11
, pp. 868
-
-
Grever, M.1
Kopecky, K.2
Head, D.3
-
59
-
-
0023945047
-
2'-deoxycoformycin (pentostatin) for lymphoid malignancies: Rational development of an active new drug
-
O'Dwyer PJ, Wagner B., Leyland-Jones B.,et al.2'-deoxycoformycin (pentostatin) for lymphoid malignancies: rational development of an active new drug. Ann Intern Med. 1988;108:733-743.
-
(1988)
Ann Intern Med.
, vol.108
, pp. 733-743
-
-
O'Dwyer, P.J.1
Wagner, B.2
Leyland-Jones, B.3
-
60
-
-
0019731629
-
Therapeutic selectivity of and prediction of response 2'-deoxycoformycin in acute leukemia
-
Prentice HG, Russell NH, Lee L.,et al.Therapeutic selectivity of and prediction of response 2'-deoxycoformycin in acute leukemia. Lancet. 1981;2: 1250-1254.
-
(1981)
Lancet
, vol.2
, pp. 1250-1254
-
-
Prentice, H.G.1
Russell, N.H.2
Lee, L.3
-
61
-
-
0020472804
-
Treatment of lymphoid malignancies with 2-deoxycoformycin: A pilot study
-
Karnofsky JR, Baron JM, Roth DG,et al.Treatment of lymphoid malignancies with 2-deoxycoformycin: a pilot study. Am J Clin Oncol. 1982;5:179-183.
-
(1982)
Am J Clin Oncol.
, vol.5
, pp. 179-183
-
-
Karnofsky, J.R.1
Baron, J.M.2
Roth, D.G.3
-
62
-
-
0019512909
-
The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy
-
Grever MR, Siaw Mfe, Jacob WFet al.The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy. Blood. 1981;57:406-417.
-
(1981)
Blood.
, vol.57
, pp. 406-417
-
-
Grever, M.R.1
Siaw, M.F.E.2
Jacob, W.F.3
-
63
-
-
79957809502
-
Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with fludarabine-associated hemolytic anemia
-
Bryd JC, Hutler AA, Weiss RB,et al.Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with fludarabine-associated hemolytic anemia. Ann Oncol.
-
Ann Oncol.
-
-
Bryd, J.C.1
Hutler, A.A.2
Weiss, R.B.3
-
64
-
-
0029046557
-
Hemolytic uremia syndrome due to deoxycorformycin: A report of the second case
-
Sakai C., Takagi T., Wakatsuki S., Matsuzaki O. Hemolytic uremia syndrome due to deoxycorformycin: a report of the second case. Intern Med. 1995;34:593-596.
-
(1995)
Intern Med.
, vol.34
, pp. 593-596
-
-
Sakai, C.1
Takagi, T.2
Wakatsuki, S.3
Matsuzaki, O.4
-
65
-
-
0025005559
-
Vomiting associated with pentostatin and pentostatin plus interferon: Unique pattern and potential mechanisms
-
Lindley CM, Bernard SA, Robertson JD Vomiting associated with pentostatin and pentostatin plus interferon: unique pattern and potential mechanisms. J Pain Symptom Manage. 1990;5:262-264.
-
(1990)
J Pain Symptom Manage
, vol.5
, pp. 262-264
-
-
Lindley, C.M.1
Bernard, S.A.2
Robertson, J.D.3
-
66
-
-
0021933387
-
Low dose deoxycoformycin in lymphoid malignancy
-
Grever MR, Leiby JM, Kraut EH,et al.Low dose deoxycoformycin in lymphoid malignancy. J Clin Oncol. 1985;3:1196-1201.
-
(1985)
J Clin Oncol.
, vol.3
, pp. 1196-1201
-
-
Grever, M.R.1
Leiby, J.M.2
Kraut, E.H.3
-
67
-
-
0025944044
-
Cardiac complications observed in elderly patients following 2'deoxycoformycin therapy
-
Grem JK, King SA, Chun HG,et al.Cardiac complications observed in elderly patients following 2'deoxycoformycin therapy. Am J Hematol. 1991;38: 245-247.
-
(1991)
Am J Hematol
, vol.38
, pp. 245-247
-
-
Grem, J.K.1
King, S.A.2
Chun, H.G.3
-
68
-
-
0021241953
-
Combination of 2'-deoxycoformycin and vidarabine in advanced malignancy: Clinical and biochemical observations
-
Grever MR, Malspeis L., Kraut EH,et al.Combination of 2'-deoxycoformycin and vidarabine in advanced malignancy: clinical and biochemical observations. Cancer Treat Symp. 1984;2:97-104.
-
(1984)
Cancer Treat Symp.
, vol.2
, pp. 97-104
-
-
Grever, M.R.1
Malspeis, L.2
Kraut, E.H.3
-
69
-
-
0020071883
-
Modulation of 9-β-d-arabinofuranosyladenine 5'-triphosphate deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-β-D-arabinofuranosyladenine
-
Plunkett W., Benjamin RS, Keating MJ,et al.Modulation of 9-β-d-arabinofuranosyladenine 5'-triphosphate deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-β-D-arabinofuranosyladenine. Cancer Res. 1982; 42:2092-2096.
-
(1982)
Cancer Res.
, vol.42
, pp. 2092-2096
-
-
Plunkett, W.1
Benjamin, R.S.2
Keating, M.J.3
-
70
-
-
0027321623
-
Pentostatin increases the acute toxicity of high dose cyclophosphamide
-
Gryn J., Gordon R., Bapat A.,et al.Pentostatin increases the acute toxicity of high dose cyclophosphamide. Bone Marrow Transplant. 1992;12:217-220.
-
(1992)
Bone Marrow Transplant.
, vol.12
, pp. 217-220
-
-
Gryn, J.1
Gordon, R.2
Bapat, A.3
-
71
-
-
0021366307
-
Severe allopurinol toxicity: Description and guidelines for prevention in patients with renal insufficiency
-
Hande KR, Noone RM, Stone WJ Severe allopurinol toxicity: description and guidelines for prevention in patients with renal insufficiency. Am J Med. 1984;7G:47-56.
-
(1984)
Am J Med.
, vol.7 G
, pp. 47-56
-
-
Hande, K.R.1
Noone, R.M.2
Stone, W.J.3
-
72
-
-
0026717636
-
Pentostatin: An adenosine deaminase inhibitor for the treatment of hairy cell leukemia
-
Kane BJ, Kuhn JG, Roush MK Pentostatin: an adenosine deaminase inhibitor for the treatment of hairy cell leukemia. Ann Pharm. 1992;26:939-947.
-
(1992)
Ann Pharm.
, vol.26
, pp. 939-947
-
-
Kane, B.J.1
Kuhn, J.G.2
Roush, M.K.3
-
73
-
-
79957825683
-
-
Product information. Nipent. Parke Davis, Morris Plains, NJ, 1991
-
Product information. Nipent. Parke Davis, Morris Plains, NJ, 1991.
-
-
-
-
74
-
-
0025050686
-
Chemical stability of pentostatin (NSC-218321): A cytotoxic and immunosuppressive agent
-
Al-Razzak LA, Benedetti AE, Waugh WN,et al.Chemical stability of pentostatin (NSC-218321): a cytotoxic and immunosuppressive agent. Pharmaceut Res. 1990;7:452-460.
-
(1990)
Pharmaceut Res.
, vol.7
, pp. 452-460
-
-
Al-Razzak, L.A.1
Benedetti, A.E.2
Waugh, W.N.3
-
75
-
-
79957829267
-
Visual compatibility of ondansetron with chemotherapeutic agents, antibiotics, and other selected drugs during simulated Y-site injection
-
Presented at the 25th Annual ASHP Midyear Clinical Meetings and Exhibit, Las Vegas, NV, Abstract P-468R
-
Trissel LA, Fulton B., Tramonte SM Visual compatibility of ondansetron with chemotherapeutic agents, antibiotics, and other selected drugs during simulated Y-site injection. Presented at the 25th Annual ASHP Midyear Clinical Meetings and Exhibit, Las Vegas, NV, 1990. Abstract P-468R.
-
(1990)
-
-
Trissel, L.A.1
Fulton, B.2
Tramonte, S.M.3
|